Center For Gene Therapeutics, Michael G. DeGroote Center for Learning and Discovery, McMaster University, Hamilton, Ontario, Canada.
PLoS Pathog. 2010 Apr 8;6(4):e1000852. doi: 10.1371/journal.ppat.1000852.
While several clinical studies have shown that HIV-1 infection is associated with increased permeability of the intestinal tract, there is very little understanding of the mechanisms underlying HIV-induced impairment of mucosal barriers. Here we demonstrate that exposure to HIV-1 can directly breach the integrity of mucosal epithelial barrier, allowing translocation of virus and bacteria. Purified primary epithelial cells (EC) isolated from female genital tract and T84 intestinal cell line were grown to form polarized, confluent monolayers and exposed to HIV-1. HIV-1 X4 and R5 tropic laboratory strains and clinical isolates were seen to reduce transepithelial resistance (TER), a measure of monolayer integrity, by 30-60% following exposure for 24 hours, without affecting viability of cells. The decrease in TER correlated with disruption of tight junction proteins (claudin 1, 2, 4, occludin and ZO-1) and increased permeability. Treatment of ECs with HIV envelope protein gp120, but not HIV tat, also resulted in impairment of barrier function. Neutralization of gp120 significantly abrogated the effect of HIV. No changes to the barrier function were observed when ECs were exposed to Env defective mutant of HIV. Significant upregulation of inflammatory cytokines, including TNF-alpha, were seen in both intestinal and genital epithelial cells following exposure to HIV-1. Neutralization of TNF-alpha reversed the reduction in TERs. The disruption in barrier functions was associated with viral and bacterial translocation across the epithelial monolayers. Collectively, our data shows that mucosal epithelial cells respond directly to envelope glycoprotein of HIV-1 by upregulating inflammatory cytokines that lead to impairment of barrier functions. The increased permeability could be responsible for small but significant crossing of mucosal epithelium by virus and bacteria present in the lumen of mucosa. This mechanism could be particularly relevant to mucosal transmission of HIV-1 as well as immune activation seen in HIV-1 infected individuals.
虽然有几项临床研究表明,HIV-1 感染与肠道通透性增加有关,但对于 HIV 引起的粘膜屏障损伤的机制知之甚少。在这里,我们证明暴露于 HIV-1 可直接破坏粘膜上皮屏障的完整性,使病毒和细菌易位。从女性生殖道和 T84 肠细胞系分离出的纯化原代上皮细胞 (EC) 培养形成极化、汇合的单层,并暴露于 HIV-1。观察到 HIV-1 X4 和 R5 嗜性实验室株和临床分离株在暴露 24 小时后,使跨上皮电阻 (TER) 降低 30-60%,TER 是衡量单层完整性的指标,而不影响细胞活力。TER 的降低与紧密连接蛋白 (claudin 1、2、4、occludin 和 ZO-1) 的破坏和通透性增加有关。EC 用 HIV 包膜蛋白 gp120 处理,但不是用 HIV tat 处理,也会导致屏障功能受损。gp120 的中和显著阻断了 HIV 的作用。当 EC 暴露于 HIV 的 Env 缺陷突变体时,对屏障功能没有观察到变化。暴露于 HIV-1 后,在肠和生殖道上皮细胞中均观察到炎症细胞因子(包括 TNF-α)的显著上调。TNF-α 的中和逆转了 TER 的降低。屏障功能的破坏与病毒和细菌穿过上皮单层的易位有关。总的来说,我们的数据表明,粘膜上皮细胞通过上调炎症细胞因子直接对 HIV-1 的包膜糖蛋白作出反应,导致屏障功能受损。通透性的增加可能是粘膜上皮中存在的少量但有意义的病毒和细菌穿过粘膜腔的原因。这种机制可能与 HIV-1 的粘膜传播以及 HIV-1 感染个体中观察到的免疫激活特别相关。